![Marc Güell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Origen de la red de primer grado Marc Güell.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Integra Therapeutics SL
![]() Integra Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Integra Therapeutics SL is a Spanish Barcelona-based company founded in 2020 by Marc Güell and Avencia Sánchez-Mejías, with Avencia Sánchez-Mejías serving as the CEO since then. The company is focused on engineering the next-generation of gene writing tools to cure genetic and oncological diseases with high unmet medical need. Integra Therapeutics is committed to creating new gene writing tools that improve the scope, efficiency, and safety of advanced therapies.
2
| Holding Company | Miscellaneous Commercial Services | 2 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Marc Güell a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Transine Therapeutics Ltd.
![]() Transine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Transine Therapeutics Ltd. is an RNA platform company based in Cambridge, UK. The British company is developing a novel class of therapeutic RNAs called SINEUPs, which can upregulate protein expression with a superior level of control and specificity across an unprecedented range of diseases and applications. The company's proprietary technology allows them to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies. The SINEUP platform boosts the expression of almost any chosen target protein by binding precisely to the mRNA that encodes it and enhancing its translation. This technology massively extends the druggable proteome and represents an entirely new mechanism of action, ideally suited to address currently hard-to-treat diseases. The company was founded in 2018 by Stefano Gustincich and Piero Carninci. Jan Thirkettle has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
Catamaran Bio, Inc.
![]() Catamaran Bio, Inc. Financial ConglomeratesFinance Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware. | Financial Conglomerates | Director/Board Member | |
Takeda Ventures, Inc.
![]() Takeda Ventures, Inc. Investment ManagersFinance Takeda Ventures Inc (Takeda Ventures) is a venture capital subsidiary of Takeda America Holdings Inc founded in 2001. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
University of Wisconsin | College/University | Masters Business Admin | |
Wesleyan University | College/University | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 5 |
Reino Unido | 2 |
Sectorial
Consumer Services | 3 |
Finance | 3 |
Health Technology | 2 |
Operativa
Director/Board Member | 3 |
Chief Executive Officer | 1 |
Founder | 1 |
Private Equity Investor | 1 |
Masters Business Admin | 1 |
Las relaciones más conectadas
Insiders | |
---|---|
Miles Gerson | 6 |
Avencia Sánchez-Mejías | 1 |
- Bolsa de valores
- Insiders
- Marc Güell
- Conexiones Empresas